Top

World Journal of Surgery

Published in:

01-06-2014

Quality of Life After Surgical Treatment of Early Barrett’s Cancer: A Prospective Comparison of the Ivor-Lewis Resection Versus the Modified Merendino Resection

Authors: Ch. Zapletal, Ch. Heesen, J. Origer, M. Pauthner, O. Pech, Ch. Ell, Dietmar Lorenz

Published in: World Journal of Surgery | Issue 6/2014

Abstract

Introduction

The Merendino (MER) procedure has been evaluated as an alternative to transthoracic esophageal resection (TER) for early stage Barrett’s carcinoma. Apart from reducing morbidity and mortality, improvements concerning postoperative health-related quality of life (HRQL) have been postulated. The aim of our study was to compare HRQL between these procedures.

Materials and methods

Between July 2000 and July 2007, 117 patients with early Barrett’s carcinoma underwent surgery. Patients with tumor recurrence were excluded from the study. HRQL was assessed 1 and 2 years after surgery using the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire (EORTC-QLQ-C30) and the QLQ-OES18 module. Patients recently diagnosed with early Barrett’s carcinoma served as controls. Symptoms that showed a difference of more than ten between the control and the study groups were considered clinically relevant and were tested for significant differences between the study groups using the Mann–Whitney U test (p < 0.05).

Results

The response rates for the questionnaires ranged between 70 and 93 %. In the MER group, more items reflected a clinical relevant impairment of HRQL than in the TER group. Significant complaints in the MER group included nausea/vomiting, appetite loss, local pain, difficulties with social eating, and choking. Moreover, we found a significant restriction concerning global health and emotional and social functioning in this group 1 year after surgery. 2 years postoperatively, hardly any differences between the operative techniques could be detected. The only symptom in favor of the MER procedure was a better dysphagia score postoperatively.

Conclusion

Our study suggests that MER procedure is not superior to subtotal esophagectomy with regard to HRQL.

Jemal A, Murray T, Ward E et al (2005) Cancer statistics. CA Cancer J Clin 1:10–30CrossRef

Buttar NS, Wang KK, Sebo TJ et al (2001) Extent of high-grade dysplasia in Barrett’s esophagus correlates with risk of adenocarcinoma. Gastroenterology 7:1630–1639CrossRef

Aldulaimi DM, Cox M, Nwokolo CU et al (2005) Barrett’s surveillance is worthwhile and detects curable cancers. A prospective cohort study addressing cancer incidence, treatment outcome and survival. Eur J Gastroenterol Hepatol 9:943–950CrossRef

Fountoulakis A, Zafirellis KD, Dolan K et al (2004) Effect of surveillance of Barrett’s oesophagus on the clinical outcome of oesophageal cancer. Br J Surg 8:997–1003CrossRef

Jamieson GG, Mathew G, Ludemann R et al (2004) Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 8:943–947CrossRef

Viklund P, Lindblad M, Lu M et al (2006) Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden. Ann Surg 2:204–211CrossRef

Scarpa M, Valente S, Alfieri R et al (2011) Systematic review of health-related quality of life after esophagectomy for esophageal cancer. World J Gastroenterol 42:4660–4674CrossRef

Scarpa M, Saadeh LM, Fasolo A et al (2013) Health-related quality of life in patients with oesophageal cancer: analysis at different steps of the treatment pathway. J Gastrointest Surg 3:421–433CrossRef

Tatematsu N, Hasegawa S, Tanaka E et al (2013) Impact of oesophagectomy on physical fitness and health-related quality of life in patients with oesophageal cancer. Eur J Cancer Care (Engl) 22(3):308–313CrossRef

10.

Chennat J, Konda VJA, Ross AS et al (2009) Complete Barrett’s eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma: an American single-center experience. Am J Gastroenterol 11:2684–2692CrossRef

11.

Dunbar KB, Spechler SJ (2012) The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systematic review. Am J Gastroenterol 6:850–862 quiz 863CrossRef

12.

Pech O, Behrens A, May A et al (2008) Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 9:1200–1206CrossRef

13.

Pech O, Bollschweiler E, Manner H et al (2011) Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett’s esophagus at two high-volume centers. Ann Surg 1:67–72CrossRef

14.

Omloo JMT, Lagarde SM, Hulscher JBF et al (2007) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 6:992–1000 discussion 1000–1001CrossRef

15.

Stein HJ, Feith M, Mueller J et al (2000) Limited resection for early adenocarcinoma in Barrett’s esophagus. Ann Surg 6:733–742CrossRef

16.

Merendino KA, Dillard DH (1955) The concept of sphincter substitution by an interposed jejunal segment for anatomic and physiologic abnormalities at the esophagogastric junction; with special reference to reflux esophagitis, cardiospasm and esophageal varices. Ann Surg 3:486–506CrossRef

17.

Gerzic ZB (1997) Modification of the Merendino procedure. Dis Esophagus 4:270–275

18.

Gaissert HA, Mathisen DJ, Grillo HC et al (1993) Short-segment intestinal interposition of the distal esophagus. J Thorac Cardiovasc Surg 5:860–866 discussion 866–867

19.

Picchio M, Lombardi A, Zolovkins A et al (1997) Jejunal interposition for peptic stenosis of the esophagus following esophagomyotomy for achalasia. Int Surg 2:198–200

20.

Parameswaran R, McNair A, Avery KNL et al (2008) The role of health-related quality of life outcomes in clinical decision making in surgery for esophageal cancer: a systematic review. Ann Surg Oncol 9:2372–2379CrossRef

21.

Bennett C, Vakil N, Bergman J et al (2012) Consensus statements for management of Barrett’s dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 2:336–346CrossRef

22.

Pech O, May A, Rabenstein T et al (2007) Endoscopic resection of early oesophageal cancer. Gut 11:1625–1634CrossRef

23.

Ando S, Tsuji H (2008) Surgical technique of vagus nerve-preserving gastrectomy with D2 lymphadenectomy for gastric cancer. ANZ J Surg 3:172–176CrossRef

24.

Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 5:365–376CrossRef

25.

Blazeby JM, Conroy T, Hammerlid E et al (2003) Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 10:1384–1394CrossRef

26.

Fayers PM (2008) Evaluating the effectiveness of using PROs in clinical practice: a role for cluster-randomised trials. Qual Life Res 10:1315–1321CrossRef

27.

Viklund P, Wengström Y, Rouvelas I et al (2006) Quality of life and persisting symptoms after oesophageal cancer surgery. Eur J Cancer 10:1407–1414CrossRef

28.

Osoba D, Rodrigues G, Myles J et al (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1:139–144

29.

King MT (1996) The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 6:555–567CrossRef

30.

de Boer AGEM, van Lanschot JJB, van Sandick JW et al (2004) Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol 20:4202–4208CrossRef

31.

Blazeby JM, Farndon JR, Donovan J et al (2000) A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 8:1781–1787CrossRef

32.

Moraca RJ, Low DE (2006) Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer. Arch Surg 6:545–549 discussion 549–551CrossRef

33.

Parameswaran R, Blazeby JM, Hughes R et al (2010) Health-related quality of life after minimally invasive oesophagectomy. Br J Surg 4:525–531CrossRef

34.

Rutegård M, Lagergren J, Rouvelas I et al (2008) Population-based study of surgical factors in relation to health-related quality of life after oesophageal cancer resection. Br J Surg 5:592–601CrossRef

35.

Barbour AP, Lagergren P, Hughes R et al (2008) Health-related quality of life among patients with adenocarcinoma of the gastro-oesophageal junction treated by gastrectomy or oesophagectomy. Br J Surg 1:80–84

36.

Djärv T, Lagergren J, Blazeby JM et al (2008) Long-term health-related quality of life following surgery for oesophageal cancer. Br J Surg 9:1121–1126CrossRef

37.

Lagergren P, Avery KNL, Hughes R et al (2007) Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer 3:686–693CrossRef

38.

Lee SS, Ryu SW, Kim IH et al (2012) Quality of life beyond the early postoperative period after laparoscopy-assisted distal gastrectomy: the level of patient expectation as the essence of quality of life. Gastric Cancer 3:299–304CrossRef

39.

Sullivan M, Tanzer M, Reardon G et al (2011) The role of presurgical expectancies in predicting pain and function one year following total knee arthroplasty. Pain 10:2287–2293CrossRef

40.

Gutschow CA, Hölscher AH, Leers J et al (2013) Health-related quality of life after Ivor Lewis esophagectomy. Langenbecks Arch Surg 398(2):231–237PubMedCrossRef

41.

Herrero LA, van Vilsteren FGI, Pouw RE et al (2011) Endoscopic radiofrequency ablation combined with endoscopic resection for early neoplasia in Barrett’s esophagus longer than 10 cm. Gastrointest Endosc 4:682–690CrossRef

42.

43.

Hölscher AH, Vallböhmer D, Gutschow C et al (2009) Reflux esophagitis, high-grade neoplasia, and early Barrett’s carcinoma: what is the place of the Merendino procedure? Langenbecks Arch Surg 3:417–424CrossRef

Title: Quality of Life After Surgical Treatment of Early Barrett’s Cancer: A Prospective Comparison of the Ivor-Lewis Resection Versus the Modified Merendino Resection
Authors: Ch. Zapletal
Ch. Heesen
J. Origer
M. Pauthner
O. Pech
Ch. Ell
Dietmar Lorenz
Publication date: 01-06-2014
Publisher: Springer US
Published in: World Journal of Surgery / Issue 6/2014
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-013-2410-1

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Quality of Life After Surgical Treatment of Early Barrett’s Cancer: A Prospective Comparison of the Ivor-Lewis Resection Versus the Modified Merendino Resection

Abstract

Introduction

Materials and methods

Results

Conclusion

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Introduction

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2014

Preoperative Factors Predicting Clinical Outcome Following Laparoscopic Fundoplication

ALPPS Offers a Better Chance of Complete Resection in Patients with Primarily Unresectable Liver Tumors Compared with Conventional-Staged Hepatectomies: Results of a Multicenter Analysis

Trends in Incidentally Identified Thyroid Cancers Over a Decade: A Retrospective Analysis of 2,090 Surgical Patients

The ALPPS Approach: Should We Sacrifice Basic Therapeutic Rules in the Name of Innovation?

The Small Abnormal Parathyroid Gland is Increasingly Common and Heralds Operative Complexity

Whole-genome Sequencing of an Aggressive BRAF Wild-type Papillary Thyroid Cancer Identified EML4–ALK Translocation as a Therapeutic Target